Canature Health Technology Co., Ltd.

SZSE:300272 Stok Raporu

Piyasa değeri: CN¥3.6b

Canature Health Technology Gelecekteki Büyüme

Future kriter kontrolleri 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Canature Health Technology.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Consumer Durables kazanç büyümesi13.1%
Gelir büyüme oranın/a
Gelecekteki özkaynak getirisin/a
Analist kapsamı

None

Son güncellemen/a

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

There's No Escaping Canature Health Technology Co., Ltd.'s (SZSE:300272) Muted Earnings Despite A 48% Share Price Rise

Oct 08
There's No Escaping Canature Health Technology Co., Ltd.'s (SZSE:300272) Muted Earnings Despite A 48% Share Price Rise

We Like These Underlying Return On Capital Trends At Canature Health Technology (SZSE:300272)

Sep 30
We Like These Underlying Return On Capital Trends At Canature Health Technology (SZSE:300272)

Canature Health Technology (SZSE:300272) Is Paying Out A Dividend Of CN¥0.10

May 27
Canature Health Technology (SZSE:300272) Is Paying Out A Dividend Of CN¥0.10

Market Might Still Lack Some Conviction On Canature Health Technology Co., Ltd. (SZSE:300272) Even After 28% Share Price Boost

May 08
Market Might Still Lack Some Conviction On Canature Health Technology Co., Ltd. (SZSE:300272) Even After 28% Share Price Boost

Canature Health Technology's (SZSE:300272) Earnings Offer More Than Meets The Eye

Apr 29
Canature Health Technology's (SZSE:300272) Earnings Offer More Than Meets The Eye

Here's Why We Think Canature Health Technology (SZSE:300272) Is Well Worth Watching

Apr 01
Here's Why We Think Canature Health Technology (SZSE:300272) Is Well Worth Watching

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak Canature Health Technology yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

SZSE:300272 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CNY Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
9/30/20241,68487219300N/A
6/30/20241,705136235321N/A
3/31/20241,681138298377N/A
12/31/20231,672132295375N/A
9/30/20231,659132288383N/A
6/30/20231,710115217322N/A
3/31/20231,69793118211N/A
1/1/20231,6619361155N/A
9/30/20221,65010945122N/A
6/30/20221,5637961116N/A
3/31/20221,5199591156N/A
1/1/20221,511105115187N/A
9/30/20211,44541123191N/A
6/30/20211,38953140202N/A
3/31/20211,30851119178N/A
12/31/20201,1812697140N/A
9/30/20201,17210170121N/A
6/30/20201,096894798N/A
3/31/20201,059912982N/A
12/31/20191,05310156114N/A
9/30/20199919460106N/A
6/30/20199249063103N/A
3/31/20199357581119N/A
12/31/20189013485596N/A
9/30/2018862321-1468N/A
6/30/2018819319N/A64N/A
3/31/2018733331N/A74N/A
12/31/201770858N/A40N/A
9/30/201768692N/A88N/A
6/30/201768994N/A60N/A
3/31/201767292N/A16N/A
12/31/201664390N/A50N/A
9/30/201659683N/A29N/A
6/30/201653381N/A60N/A
3/31/201648877N/A80N/A
12/31/201545776N/A80N/A
9/30/201540072N/A67N/A
6/30/201539368N/A61N/A
3/31/201538165N/A67N/A
12/31/201437564N/A80N/A
9/30/201436364N/A73N/A
6/30/201434560N/A68N/A
3/31/201432658N/A61N/A
12/31/201331157N/A48N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: Insufficient data to determine if 300272's forecast earnings growth is above the savings rate (2.9%).

Kazançlar ve Piyasa: Insufficient data to determine if 300272's earnings are forecast to grow faster than the CN market

Yüksek Büyüme Kazançları: Insufficient data to determine if 300272's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: Insufficient data to determine if 300272's revenue is forecast to grow faster than the CN market.

Yüksek Büyüme Geliri: Insufficient data to determine if 300272's revenue is forecast to grow faster than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if 300272's Return on Equity is forecast to be high in 3 years time


Büyüyen şirketleri keşfedin